Palo Alto? Well, there goes the nice "don't really need to wake up first" convenience of Berkeley.......
Friday November 5, 9:09 pm Eastern Time
Company Press Release
SOURCE: Informed Investors, Inc.
Second Annual SF Bay Area Drug Delivery Stocks
Forum Saturday, November 20, 1999 in Palo Alto
WHEN: 8:30 a.m.-12:15 p.m., Saturday, November 20, 1999
(Reg./Breakfast at 8)
WHERE: Crowne Plaza, Palo Alto, CA 4290 El Camino Real 650-857-0787
COST TO ATTEND: $25 Prepaid: $40 At The Door (Includes Breakfast)
REGISTRATION: Call 800-992-4683 or online at informedinvestors.comfocus: Drug Delivery Stocks
KEYNOTE SPEAKERS: John Rende, Biotech Buyside Analyst for Weintraub Capital Management; Kellie Seringer, Biotech
Analyst of Evolution Capital
FORMAT: Analyst-style presentations from top executives of firms followed by Q&A
AUDIOSTREAMING: Hear the Forum live (and archived) via www.informedinvestors.com
PRESENTING COMPANIES: Matrix Pharmaceuticals (Nasdaq: MATX - news), Inhale Therapeutics (Nasdaq: INHL -
news), Collateral Therapeutics (Nasdaq: CLTX - news), Aradigm (Nasdaq: ARDM - news), Anesta Corp. (Nasdaq: NSTA -
news); SkyePharma (Nasdaq: SKYE - news)
PROFILES OF KEYNOTE SPEAKERS
Kellie Seringer is a principal and senior research analyst at Evolution Capital. Kellie follows the health care industry which
includes biotechnology and drug delivery companies. Kellie joined Evolution Capital in December of 1997. Prior to joining
Evolution Capital, she was an associate analyst covering the pharmaceutical and biotechnology industries at Montgomery
Securities with John Borzilleri, MD. She also served as an associate analyst covering pharmaceuticals and drug delivery at
Dean Witter Reynolds. Seringer earned her BS in Biochemistry and Genetics from Texas A&M University.
John Rende is a Biotech Analyst and Partner at Wentraub Capital Management. A Bay Area native, after graduation from
Claremont McKenna College in 1989, he joined America Bionetics, a biotech firm specializing in the research and design of
HIV confirmatory tests. After 15 months there, he joined Wells Fargo Asset Management as an analyst and subsequently was
managing more than $950 million in assets. Rende was made regional manager of the New York office of Wells Fargo Asset
Management in 1994. He joined Weintraub in July 1996.
CONTACT: Steve Chanecka, or Tim Quast of InformedInvestors.com, 916-448-8222, or 800-992-4683.
SOURCE: Informed Investors, Inc. |
